scispace - formally typeset
Open AccessJournal ArticleDOI

The incidence and mortality of major cancers in China, 2012.

Reads0
Chats0
TLDR
Continuous cancer registry data provides basic information in cancer control programs, and the cancer burden in China is gradually increasing, both in urban and rural areas, in males and females.
Abstract
The National Central Cancer Registry (NCCR) collected population-based cancer registration data in 2012 from local registries and estimated the cancer incidence and mortality in China. In the middle of 2015, 261 cancer registries submitted reports on new cancer cases and deaths occurred in 2012. Qualified data from 193 registries were used for analysis after evaluation. Crude rates, number of cases, and age-standardized rates stratified by area (urban/rural), sex, age group, and cancer type were calculated according to the national population in 2012. The covered population were 198,060,406 from 193 qualified cancer registries (74 urban and 119 rural registries). The major indicators of quality control, percentage of cases morphologically verified (MV%), death certificate-only cases (DCO%), and the mortality to incidence (M/I) ratio, were 69.13%, 2.38%, and 0.62, respectively. It was estimated that there were 3,586,200 new cancer cases and 2,186,600 cancer deaths in 2012 in China with an incidence of 264.85/100,000 [age-standardized rate of incidence by the Chinese standard population (ASRIC) of 191.89/100,000] and a mortality of 161.49/100,000 [age-standardized rate of mortality by the Chinese standard population (ASRMC) of 112.34/100,000]. The ten most common cancer sites were the lung, stomach, liver, colorectum, esophagus, female breast, thyroid, cervix, brain, and pancreas, accounting for approximately 77.4% of all new cancer cases. The ten leading causes of cancer death were lung cancer, liver cancer, gastric cancer, esophageal cancer, colorectal cancer, pancreatic cancer, female breast cancer, brain tumor, leukemia, and lymphoma, accounting for 84.5% of all cancer deaths. Continuous cancer registry data provides basic information in cancer control programs. The cancer burden in China is gradually increasing, both in urban and rural areas, in males and females. Efficient cancer prevention and control, such as health education, tobacco control, and cancer screening, should be paid attention by the health sector and the whole society of China.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Cancer statistics in China, 2015

TL;DR: Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations.
Journal ArticleDOI

The global burden of liver disease: The major impact of China

TL;DR: The epidemiology and characteristics of liver diseases and liver‐related research in China are discussed and many challenges remain that must be tackled collaboratively.
Journal ArticleDOI

Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment.

TL;DR: It is suggested that Wnt signaling might have a critical role in the self-renewal of gastric CSCs, and salinomycin targeting WNT signaling may have important clinical applications in gastric cancer therapy.

The updated incidences and mortalitiesof major cancers in China, 2011

TL;DR: The population covered by the cancer registries greatly increased from 2010 to 2011 and the data quality and representativeness ofcancer registries have gradually improved, indicating that cancer Registries have an irreplaceable role in research on cancer prevention and control.
Journal ArticleDOI

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.

TL;DR: An overview of the Notch signal in NSCLC is provided: its biological significance and therapeutic application, which shows promising effect in some cancer patients received treatment with Notch1 inhibitor.
References
More filters
Book

Cancer Incidence in Five Continents

TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

TL;DR: The routines in place at the CRN yields comparable data that can be considered reasonably accurate, close-to-complete and timely, thereby justifying the policy of the reporting of annual incidence one year after the year of diagnosis.
Journal ArticleDOI

Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness

TL;DR: An update of the practical aspects and techniques for addressing data quality at the cancer registry is provided, namely, the comparability, validity and timeliness of cancer registry data.
Journal ArticleDOI

Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness.

TL;DR: This second instalment of a two-part review of data quality methods at the cancer registry focuses on the principles and techniques available for estimating completeness, separating methods into those that are semi-quantitative -- in that they give an indication of the degree of completeness relative to other registries or over time, and more quantitative techniques -- those that provide a numerical evaluation.
Journal ArticleDOI

The evolution of the population-based cancer registry

TL;DR: This Review looks at the current status of cancer registration practice and use from an international perspective, mindful that the registration of cancer has expanded into a global activity.
Related Papers (5)